Share
Journal Information
Issue
Vol. 10. Issue 4.Pages 417-588 (October - December 2011)
From the editor
Hepatology highlights
Concise review
Pre operative cardio pulmonary assessment of the liver transplant candidate
Graciela Martinez-Palli, Andrés Cárdenas
Ann Hepatol. 2011;10:421-33
Open access
Original article
Evolution of hepatitis B virus during long-term therapy in patients with chronic hepatitis B (♦)
Elisabete Arrese, Miren Basaras, Sonia Blanco, Pablo Ruiz, Ramόn Cisterna
Ann Hepatol. 2011;10:434-40
Open access
The role of hepatitis B immunoglobulin in hepatitis B related liver transplantation: Canadian Transplant Centre Position Paper
Mark Levstik, Philip Wong, Erica D. Greanya, Eric M. Yoshida
Ann Hepatol. 2011;10:441-4
Open access
No association of promoter variations of HMOX1 and UGT1A1 genes with liver injury in chronic hepatitis C(♦)
Petr Urbánek, Martin Leníček, Lucie Muchová, Iva Subhanová, Ladislav Dušek, Nikola Kaspříkova, Petr Hrabal, Radan Brůha, Libor Vítek
Ann Hepatol. 2011;10:445-51
Open access
Genetic variation in Interleukin-28B predicts SVR in hepatitis C genotype 1 Argentine patients treated with PEG IFN and ribavirin
Ezequiel Ridruejo, Ángela Solano, Sebastián Marciano, Omar Galdame, Raúl Adrover, Daniel Cocozzella, Dreanina Delettieres, Alfredo Martínez, ... Marcelo O. Silva
Ann Hepatol. 2011;10:452-7
Open access
Danazol improves thrombocytopenia in HCV patients treated with peginterferon and ribavirin
Guillermo Cabrera Álvarez, Diana Gόmez-Galicia, Lourdes Rodríguez-Fragoso, Vicente Madrid Marina, Luis Cañedo Dorantes, Miguel Sánchez-Alemán, Nahum Méndez-Sánchez, Jorge Reyes Esparza
Ann Hepatol. 2011;10:458-68
Open access
Impact of Fibroscan® on management of chronic viral hepatitis in clinical practice
Dietje Fransen van de Putte, Renske Blom, Hanneke van Soest, Marco Mundt, Claudia Verveer, Joop Arends, Robert E. de Knegt, Eveline Mauser-Bunschoten, Karel van Erpecum
Ann Hepatol. 2011;10:469-76
Open access
Do older patients utilize excess health care resources after liver transplantation?
Neil Shankar, Mamoun AlBasheer, Paul Marotta, William Wall, Vivian McAlister, Natasha Chandok
Ann Hepatol. 2011;10:477-81
Open access
Should donation after cardiac death liver grafts be used for retransplantation?
Dana K. Perry, Darrin L. Willingham, Lena Sibulesky, Ilynn G. Bulatao, Justin H. Nguyen, C. Burcin Taner
Ann Hepatol. 2011;10:482-5
Open access
Decrease of aminotransferase levels in obese women is related to body weight reduction, irrespective of type of diet(♦)
Heriberto Rodrŕguez-Hernández, Miriam Cervantes-Huerta, Martha Rodrŕguez-Moran, Fernando Guerrero-Romero
Ann Hepatol. 2011;10:486-92
Open access
Plasminogen activator inhibitor type 1 serum levels and 4G/5G gene polymorphism in morbidly obese Hispanic patients with non-alcoholic fatty liver disease(♦)
Alberto Espino, Andrea Villagrán, Valeska Vollrath, Paulina Hanckes, Roberto Salas, Andrea Farah, Nancy Solís, Margarita Pizarro, ... Arnoldo Riquelme
Ann Hepatol. 2011;10:493-501
Open access
Alcohol use among patients with HIV infection
Maurizio Bonacini
Ann Hepatol. 2011;10:502-7
Open access
Differential diagnosis of malignant epithelial tumours in the liver: an immunohistochemical study on liver biopsy material
Najla Al-Muhannadi, Naseem Ansari, Urmil Brahmi, Ali Abdel Satir
Ann Hepatol. 2011;10:508-15
Open access
Alteration of AP-endonuclease1 expression in curcumin-treated fibrotic rats
Ahmad R. Bassiouny, Amira Zaky, Faten Fawky, Kamal M. Kandeel
Ann Hepatol. 2011;10:516-30
Open access
Glutamine prevents gastric oxidative stress in an animal model of portal hypertension gastropathy(◆)
Camila Marques, José L. Mauriz, Douglas Simonetto, Claudio A. Marroni, María J. Tuñon, Javier González-Gallego, Norma P. Marroni
Ann Hepatol. 2011;10:531-9
Open access
Protective effect of Thymic Humoral Factor on porcine serum-induced hepatic fibrosis and liver damage in Wistar rats
Ulises Osuna-Martínez, Jorge Alberto Reyes-Esparza, Vera L. Petricevich, Rogelio Hernández-Pando, Lourdes Rodríguez-Fragoso
Ann Hepatol. 2011;10:540-51
Open access
Editorial
IgG4-related sclerosing cholangitis
Terumi Kamisawa, Taku Tabata
Ann Hepatol. 2011;10:552-5
Open access
Liver cirrhosis and hepatocellular carcinoma in Mexico: impact of chronic infection by hepatitis viruses B and C
Kirvis Torres-Poveda, Ana I. Burguete-García, Vicente Madrid-Marina
Ann Hepatol. 2011;10:556-8
Open access
Images in hepatology
Takayasu arteritis associated with hepatic sinusoidal dilatation
Cécile Durant, Jérome Martin, Baptiste Hervier, Jérome Gournay, Mohamed Hamidou
Ann Hepatol. 2011;10:559-61
Open access
Case report
Recurrent liver failure caused by IgG4 associated cholangitis
Jacob N. Clendenon, Jaime Aranda-Michel, Murli Krishna, C. Burcin Taner, Darrin L. Willingham
Ann Hepatol. 2011;10:562-4
Open access
Cholestasis as the initial presentation of relapsing polychondritis
Maria da Graça Ferronato, Leonardo Jönck Staub, Renata Cristina Teixeira Pinto Viana, Lígia da Rosa, Maria Beatriz Cacese Shiozawa, Janaína L. Narciso-Schiavon, Esther Buzaglo Dantas-Correa, Leonardo de Lucca Schiavon
Ann Hepatol. 2011;10:565-7
Open access
Hepatotoxicity from ingestion of wild mushrooms of the genus Amanita section Phalloideae collected in Mexico City: two case reports
Jorge Méndez-Navarro, Nayeli X. Ortiz-Olvera, Margarita Villegas-Ríos, Luis J. Méndez-Tovar, Karin L. Andersson, Rosalba Moreno-Alcantar, Víctor E. Gallardo-Cabrera, Sergio Félix, ... Margarita Dehesa-Violante
Ann Hepatol. 2011;10:568-74
Open access
Letter to editor
Citrus auraptene: A potential multifunctional therapeutic agent for nonalcoholic fatty liver disease
Amirhossein Sahebkar
Ann Hepatol. 2011;10:575-7
Open access
Liver news elsewhere
Hepatitis A virus infection in high-risk subjects
Tonatiuh Barrientos-Gutiérrez, Diana Brizuela-Alcántara, Norberto C. Chávez-Tapia
Ann Hepatol. 2011;10:578-9
Open access
Special notice
Index to volume
Publish in
Annals of Hepatology
Special content about COVID-19
- Outcomes and factors associated with relapse of vaccine-induced liver injury after SARS CoV-2 immunization: A nationwide study
- Matrix metalloproteinase-2 inducing COL1A1 synthesis via integrin alpha Ⅴ promotes invasion and metastasis of cholangiocarcinoma cells
- P-2 NASH IS IMPROVED THROUGH MODIFICATIONS IN H3K9 METHYLATION BY PIRFENIDONE ACTING AS JMJD2B DEMETHYLASE ANTAGONIST.
- O-2 EVALUATION OF RISK FACTORS AND PROGNOSIS OF HEPATOCELLULAR CARCINOMA RECURRENCE AFTER LIVER TRANSPLANTATION
Affiliated societies
